Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 929 - 929
Published: April 9, 2025
Chronic
allograft
nephropathy
is
the
leading
cause
of
kidney
failure.
Clinically,
it
characterized
by
a
progressive
decline
in
function,
often
combination
with
proteinuria
and
hypertension.
Histologically,
interstitial
fibrosis
tubular
atrophy,
along
features
glomerulosclerosis
occasional
double
contour
appearance,
arteriolar
hyalinosis,
arteriosclerosis,
are
characteristic
findings.
The
pathophysiology,
though
complex
incompletely
understood,
thought
to
involve
sequence
immunologic
non-immunologic
injuries
eventually
tissue
remodeling
scarring
within
graft.
optimal
strategy
prevent
chronic
minimize
both
immune-
non-immune-mediated
graft
injury.
Transplantation,
Journal Year:
2022,
Volume and Issue:
107(2), P. 438 - 448
Published: Aug. 22, 2022
Background
.
We
evaluated
whether
the
use
of
normothermic
regional
perfusion
(NRP)
was
associated
with
increased
organ
recovery
and
improved
transplant
outcomes
from
controlled
donation
after
circulatory
death
(cDCD).
Methods
This
is
a
retrospective
analysis
UK
adult
cDCD
donors‚
where
at
least
1
abdominal
accepted
for
transplantation
between
January
1,
2011,
December
31,
2019.
Results
A
mean
3.3
organs
transplanted
when
NRP
used
compared
2.6
per
donor
not
used.
When
adjusting
organ-specific
risk
profiles,
odds
all
being
by
3-fold
liver
(
P
<
0.0001;
95%
confidence
interval
[CI],
2.20-4.29),
1.5-fold
kidney
=
0.12;
CI,
0.87-2.58),
1.6-fold
pancreas
0.0611;
0.98-2.64).
Twelve-mo
survival
superior
recipients
graft
51%
lower
risk-adjusted
hazard
failure
(HR
0.494).
In
analyses,
kidneys
had
35%
chance
developing
delayed
function
than
non-NRP
(odds
ratio,
0.65;
0.465-0.901)‚
expected
12-mo
estimated
glomerular
filtration
rate
6.3
mL/min/1.73
m
2
better
if
0.0001).
Conclusions
The
during
DCD
leads
to
utilization
conventional
recovery.
Nature Medicine,
Journal Year:
2023,
Volume and Issue:
29(6), P. 1511 - 1519
Published: May 25, 2023
Kidney
transplantation
is
the
optimal
treatment
for
end-stage
renal
disease,
but
it
still
severely
limited
by
a
lack
of
suitable
organ
donors.
Kidneys
from
donation
after
circulatory
death
(DCD)
donors
have
been
used
to
increase
transplant
rates,
these
organs
are
susceptible
cold
ischemic
injury
in
storage
period
before
transplantation,
clinical
consequence
which
high
rates
delayed
graft
function
(DGF).
Normothermic
machine
perfusion
(NMP)
an
emerging
technique
that
circulates
warmed,
oxygenated
red-cell-based
perfusate
through
kidney
maintain
near-physiological
conditions.
We
conducted
randomized
controlled
trial
compare
outcome
DCD
transplants
conventional
static
(SCS)
alone
or
SCS
plus
1-h
NMP.
A
total
338
kidneys
were
randomly
allocated
(n
=
168)
NMP
170),
and
277
included
final
intention-to-treat
analysis.
The
primary
endpoint
was
DGF,
defined
as
requirement
dialysis
first
7
d
transplant.
rate
DGF
82
135
(60.7%)
versus
83
142
(58.5%)
(adjusted
odds
ratio
(95%
confidence
interval)
1.13
(0.69-1.84);
P
0.624).
not
associated
with
any
thrombosis,
infectious
complications
other
adverse
events.
at
end
did
reduce
kidneys.
demonstrated
be
feasible,
safe
application.
Trial
registration
number:
ISRCTN15821205
.
Transplantation Direct,
Journal Year:
2023,
Volume and Issue:
9(3), P. e1450 - e1450
Published: Feb. 17, 2023
Normothermic
regional
perfusion
(NRP)
has
gained
widespread
adoption
in
multiple
European
countries.
The
aim
of
this
study
was
to
examine
the
influence
thoracoabdominal-NRP
(TA-NRP)
on
utilization
and
outcomes
liver,
kidney,
pancreas
transplantation
United
States.Using
US
national
registry
data
between
2020
2021,
donation
after
circulatory
death
(DCD)
donors
were
separated
into
2
groups:
DCD
with
TA-NRP
without
TA-NRP.
There
5234
donors;
among
them
34
After
1:4
propensity
score
matching,
rates
compared
TA-NRP.Although
kidney
comparable
(P
=
0.71
P
0.06,
94.1%
versus
95.6%
8.8%
2.2%,
respectively),
that
liver
significantly
higher
<
0.001;
70.6%
39.0%).
Among
24
transplantations,
62
3
transplantations
from
TA-NRP,
there
grafts
1
graft
failed
within
y
transplantation.TA-NRP
States
increased
rate
abdominal
organs
transplantation.
Increasing
use
NRP
may
expand
donor
pool
compromising
transplant
outcomes.
EClinicalMedicine,
Journal Year:
2023,
Volume and Issue:
58, P. 101887 - 101887
Published: March 2, 2023
BackgroundHeart
transplantation
is
an
effective
treatment
offering
the
best
recovery
in
both
quality
and
quantity
of
life
those
affected
by
refractory,
severe
heart
failure.
However,
limited
donor
organ
availability.
The
reintroduction
donation
after
circulatory
determination
death
(DCD)
2014
offered
uplift
transplant
activity
30%.
Thoraco-abdominal
normothermic
regional
perfusion
(taNRP)
enables
in-situ
reperfusion
DCD
heart.
objective
this
paper
to
assess
clinical
outcomes
hearts
recovered
transplanted
from
donors
undergoing
taNRP.MethodThis
was
a
multicentre
retrospective
observational
study.
Outcomes
included
functional
warm
ischaemic
time,
use
mechanical
support
immediately
following
transplantation,
perioperative
long-term
actuarial
survival
incidence
acute
rejection
requiring
treatment.
157
taNRP
transplants,
performed
between
February
2,
2015,
July
29,
2022,
have
been
15
major
centres
worldwide
including
UK,
Spain,
USA
Belgium.
673
donations
neurological
(DBD)
transplantations
same
were
used
as
comparison
group
for
survival.FindingstaNRP
resulted
23%
increase
activity.
Survival
similar
when
compared
DBD.
30-day
96.8%
([92.5%–98.6%]
95%
CI,
n
=
156),
1-year
93.2%
([87.7%–96.3%]
72)
5-year
84.3%
([69.6%–92.2%]
13).InterpretationOur
study
suggests
that
provides
significant
boost
rates
are
comparable
obtained
DBD
may
part
be
related
short
time
or
through
possible
selection
bias
younger
donors,
being
uncontrolled
Therefore,
our
offers
method
preservation
procurement.
This
early
success
technique
warrants
further
investigation
use.FundingNone
authors
financial
relationship
with
commercial
entity
has
interest
subject.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(12), P. 3871 - 3871
Published: June 6, 2023
The
high
demand
for
organs
in
kidney
transplantation
and
the
expansion
of
donor
pool
have
led
to
widespread
implementation
machine
perfusion
technologies.
In
this
study,
we
aim
provide
an
up-to-date
systematic
review
developments
expanding
field
over
past
10
years,
with
answering
question:
“which
technique
is
most
promising
transplantation?”
A
literature
related
was
performed.
primary
outcome
measure
delayed
graft
function
(DGF),
secondary
outcomes
included
rates
rejection,
survival,
patient
survival
after
1
year.
Based
on
available
data,
a
meta-analysis
results
were
compared
data
from
static
cold
storage,
which
still
standard
care
many
centers
worldwide.
total
56
studies
conducted
humans
included,
43
reported
hypothermic
(HMP),
DGF
rate
26.4%.
16
showed
significantly
lower
HMP
group
those
storage
(SCS).
Five
+
O2,
overall
29.7%.
Two
explored
normothermic
(NMP).
These
pilot
studies,
designed
assess
feasibility
approach
clinical
setting.
Six
regional
(NRP).
incidence
71.5%,
as
it
primarily
used
uncontrolled
DCD
(Maastricht
category
I-II).
Three
comparing
NRP
situ
NRP.
evidence
that
dynamic
preservation
strategies
can
improve
following
transplantation.
More
recent
approaches
such
O2
do
show
but
need
further
This
study
shows
could
play
important
role
safely
pool.
Artificial Organs,
Journal Year:
2021,
Volume and Issue:
46(2), P. 191 - 200
Published: Dec. 8, 2021
Abstract
Introduction
Several
clinical
studies
have
demonstrated
the
safety,
feasibility,
and
efficacy
of
machine
perfusion
in
liver
transplantation,
although
its
economic
outcomes
are
still
underexplored.
This
review
aimed
to
examine
costs
related
associated
outcomes.
Methods
Expert
opinion
several
groups
representing
different
modalities.
Critical
analysis
published
literature
reporting
most
used
techniques
transplantation
(normothermic
hypothermic
ex
situ
normothermic
regional
perfusion).
Results
Machine
include
disposable
components
device,
perfusate
components,
personnel
facility
fees,
depreciation
device
or
lease
fee.
The
limited
current
suggests
that
this
upfront
cost
varies
between
modalities,
use
is
highly
likely
be
cost‐effective.
Optimization
donor
utilization
rate,
local
conditions
transplant
programs
(long
waiting
list
times
higher
MELD
scores),
a
decreased
rate
complications,
changes
logistics,
length
hospital
stay
potential
savings
points
must
highlight
expected
benefits
intervention.
An
additional
unaccounted
factor
optimizing
organ
allows
patients
transplanted
earlier,
avoiding
deterioration
while
on
with
admissions
other
required
procedures.
Conclusion
So
far,
guided
implementation
transplantation.
Albeit
there
data
suggesting
benefit
technique,
further
investigation
healthcare
systems
society
needed.